Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Potential use of MLN-518 in AML and high-risk MDS

Dec. 13, 2002

Paladin returns Canadian DepoCyt rights to SkyePharma

Dec. 13, 2002

TLK-286 enters two new combination trials

Dec. 13, 2002

Telomerase inhibitors under study at Pharmacia

Dec. 13, 2002

Inhibition of Src tyrosine kinases as a novel approach to the treatment of CML

Dec. 12, 2002

Exherin cleared to enter phase I trials in Canada

Dec. 12, 2002

NanoCarrier and Kirin collaborate on anticancer therapeutics

Dec. 12, 2002

Apomine as a new therapeutic approach to multiple myeloma

Dec. 12, 2002

New caspase activators in Cytovia development pipeline

Dec. 12, 2002

Pipecolinate MDR modulators effective in modulating mitoxantrone efflux from AML cells

Dec. 11, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...